Eric Schmidt of Novell. He presided over a period of decline at Novell where its IPX protocol was being replaced by open TCP/IP products, while at the same time Microsoft was shipping free TCP/IP stacks in Windows 95, making Novell much less profitable. In 2001, he departed after the acquisition of Cambridge Technology Partners. Google founders Larry Page and Sergey Brin interviewed Schmidt. Impressed by him, they recruited Schmidt to run their company in 2001 under the guidance of venture capitalists John Doerr and Michael Moritz. In March 2001, Schmidt joined Google's board of directors as chairman, and became the company's CEO
MannKind Corporation in 2001 from Solomon Steiner; with that purchase MannKind acquired the Technosphere molecule and Medtone inhaler, upon which was developed its lead product, Afrezza (inhalable insulin). Mann was chief executive officer until January 12, 2015 when Hakan Edstrom became CEO and Mann transitioned to executive chairman. In November 2015, Hakan Edstrom stepped down as CEO and president and will remain until July, 2017 to provide other services for the company. Company founder Alfred Mann stepped in as interim CEO on November 19, 2015. In May 2017, Michael Castagna was named CEO of MannKind Corporation. MannKind's corporate headquarters are in Westlake